Results from an international phase 2 study of the anti‐CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B‐lineage acute lymphoblastic leukemia
暂无分享，去创建一个
I. Pastan | A. Baruchel | F. Locatelli | Y. Bertrand | J. Moppett | Paul L Martin | F. Méchinaud | D. Bhojwani | N. Hijiya | S. Rheingold | L. Dalla-Pozza | N. Shah | A. Wayne | Xia Li | T. Trippett | K. August | C. Schmitt | I. Vainshtein | M. Liang | N. Yao | J. Boklan | Robyn M. Dennis | K. Balic | R. Dennis | F. Mechinaud | P. Martin | Jessica Boklan